RevolKa was featured on Nikkei Biotechnology & Business

2021/12/06

日経バイオテクに当社代表片岡のインタビュー記事が掲載されました。

https://bio.nikkeibp.co.jp/atcl/column/16/021500017/120100219/

RevolKa raised funds through a startup loan program

RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs

RevolKa Started joint research of a drug discovery program for rare diseases

Related Articles